Literature DB >> 12297697

MRI of blood volume and cellular uptake of superparamagnetic iron in an animal model of choroidal melanoma.

Matthias Krause1, Kenneth K Kwong, Jing Xiong, Evangelos S Gragoudas, Lucy H Y Young.   

Abstract

Functional magnetic resonance imaging (MRI), using monocrystalline iron oxide nanoparticles (MION) as a new intravascular contrast agent, was adapted for a rabbit model of pigmented choroidal melanoma. Three-dimensionally spoiled gradient recalled sequences were used for the quantitative assessment of blood volume and cellular uptake. In all ocular tissues studied, MION reduced the T(2)-weighted signal intensity within 0.5 h and at 24 h (both p < 0.05) after the injection. In individual tumors, MION reduced the T(2)-weighted signal intensity by 46-78% within 0.5 h and by 24-48% at 24 h. In addition, MION increased the T(1)-weighted signal intensity in all tissues. T(2) yielded a higher sensitivity than T(1)-weighted images. Functional MRI with MION is a noninvasive technique with regard to the eye, permitting measurement of blood volume and cellular uptake of the contrast agent. Further study is necessary to determine the feasibility of this technique for the tumor diagnosis and evaluation of tumor viability following treatments. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297697     DOI: 10.1159/000063883

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  7 in total

1.  Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles.

Authors:  K K Pohaku Mitchell; S Sandoval; M J Cortes-Mateos; J G Alfaro; A C Kummel; W C Trogler
Journal:  J Mater Chem B       Date:  2014-12-07       Impact factor: 6.331

2.  Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.

Authors:  Lova Sun; Daniel Y Joh; Ajlan Al-Zaki; Melissa Stangl; Surya Murty; James J Davis; Brian C Baumann; Michelle Alonso-Basanta; Gary D Kaol; Andrew Tsourkas; Jay F Dorsey
Journal:  J Biomed Nanotechnol       Date:  2016-02       Impact factor: 4.099

Review 3.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 4.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

5.  Measurement of human choroidal melanoma xenograft volume in rats using high-frequency ultrasound.

Authors:  Rod D Braun; Kerry S Vistisen
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

6.  Animal Models of Uveal Melanoma.

Authors:  Ogul E Uner; Nikhila Gandrakota; Corrina P Azarcon; Hans E Grossniklaus
Journal:  Ann Eye Sci       Date:  2022-03-15

Review 7.  Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Authors:  Marta M Stei; Karin U Loeffler; Frank G Holz; Martina C Herwig
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.